A randomized clinical trial on 84 pregnant women with GDM between 24 and 28-weeks of gestation investigated the effect of myo-inositol supplementation on insulin resistance parameters using the insulin resistance index (HOMA-IR) and adiponectin circulating levels. This evidence concerns the gene ADIPOQ and gestational diabetes.